NCT07570654Phase 2, phase 3Recruiting

Redefine Study: A Study Evaluating the Efficacy, Safety, and Tolerability of COMP360 in Participants With Post-traumatic Stress Disorder

Study sponsor: COMPASS Pathways

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2028-11Estimated
Enrollment · participants300Estimated
Source updated2026-11-12Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 1 field changed

Recruitment status changed

Before: Not yet recruiting. After: Recruiting.

Check registry source